1Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo[J]. N Engl J Med, 1991, 324(12): 781-788. 被引量：1
2Wyse DG, Slee A, Epstein AE, et ah Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience[J]. Heart Rhythm, 2004, 1(5): 531-537. 被引量：1
3Villafafie J, Atallah J, Gollob MH, et al. Long-term follow-up of a pediatric cohort with short QT syndrome[J]. J Am Coll Cardiol, 2013, 61(11): 1183-1191. 被引量：1
4Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur Heart J, 2012, 33(20): 2569-2619. 被引量：1
5Spencer B, Chacko J, Sallee D. The 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiac care: an overview of the changes to pediatric basic and advanced life support [J]. Crit Care Nurs Clin North Am, 2011, 23(2): 303-310. 被引量：1
6Mizzi A, Tran T, Mangar D, et al. Amiodarone supplants lidocaine in ACLS and CPR protocols[J]. Anesthesiol Clin, 2011, 29(3): 535-545. 被引量：1
7Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death[J]. Circulation, 2006, 114(10): E385-E484. 被引量：1
8Shimizu W, Tanabe Y, Aiba T, et al. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome[J]. J Am Coil Cardiol, 2002, 39(12): 1984-1991. 被引量：1
9Mizusawa Y, Horie M, Wilde AA. Genetic and clinical advances in congenital long QT syndrome [J]. Circ J, 2014, 78(12): 2827-2833. 被引量：1
10Bhuiyan ZA, A1-Shahrani S, A1-Aama J, et al. Congenital long QT syndrome: an update and present perspective in Saudi Arabia[J]. Front Pediatr, 2013, 1: 39. 被引量：1
